GTS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
<br />
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Neurofibromatosis Type 1 (NF1)]]
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|7/12/2023
|
|PENDING
|
|Madina Sukhanova (Madina S)
|
|Named based on GTS5 book
|-
|[[Familial Adenomatous Polyposis (APC)]]
|Disease
|Jennifer Laffin
|8/20/2023
|
|PENDING
|
|MS / LS
|
|Named based on GTS5 book
|-
|[[Peutz-Jeghers Syndrome (STK11)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Li-Fraumeni Syndrome (TP53)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)]]||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)|''BRCA''-Related Cancer Predisposition Syndrome (''BRCA1'', ''BRCA2'')]]
|Disease
|Constance Albarracin / Katherine Geiersbach
|
|
|PENDING
|
|Katherine Geiersbach
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]
|Disease
|Constance Albarracin / Katherine Geiersbach / Jun Liao
|
|
|PENDING
|
|Katherine Geiersbach
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[Ataxia-Telangiectasia Syndrome (ATM)]]
|Disease
|Evin Gulbahce / Katherine Geiersbach
|
|
|PENDING
|
|Katherine Geiersbach
|
|Named based on GTS5 book (page created 12/30/23)
|-
|[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]
|Disease
|
|
|
|
|
|
|
|Named based on GTS5 book (page created 12/30/23)
|-
|CHAPTER 6 (TELOMERE MAINTENANCE)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|CHAPTER 8 (RNA REGULATION)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[DICER1-Related Tumour Predisposition Syndrome (DICER1)]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|CHAPTER 9 (PROTEIN REGULATION)
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|}
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>